Top news
All coverage
Georgia becomes third state to shut down Johnson & Johnson vaccine site after adverse reactions
By Nikki Battiste
FDA advises states to pause use of J&J Covid vaccine after rare blood-clotting issue affects 6 women, kills 1
By Berkeley Lovelace, Berkeley Lovelace Jr. & Dawn Kopecki
Johnson & Johnson vaccine deliveries plunge as company backs off previous April target
By Christopher Rowland
Covid-19: Johnson & Johnson Vaccine Pause Is Another Hurdle For Europe (Published 2021)
By Denise Grady, Asmaa Al-omar & Anna Schaverien
U.S. states face steep decline in J&J Covid vaccine amid production problems at Baltimore plant
By Emma Newburger
Johnson & Johnson Shots to Stay Scarce in U.S. Until Plant Is Approved, White House Official Says (Published 2021)
By Julie Bosman, Sharon LaFraniere & Heather Murphy
U.S. Calls for Pause on Johnson & Johnson Vaccine After Blood Clotting Cases
By Carl Zimmer, Sharon LaFraniere & Noah Mercer Weiland
FDA, CDC call for pause in use of Johnson & Johnson vaccine after 'extremely rare' cases of blood clots
By Lena Sun, Carolyn Johnson & Laurie McGinley